Liu YANG

Ms. Liu YANG


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
SXSiyu Xiang
Siyu Xiang
LYLiu YANG
Liu YANG
YHYun He
Yun He
FDFeng Ding
Feng Ding
SQShuangying Qiao
Shuangying Qiao
LFLi Fangfei
Li Fangfei
Alpha-1 antitrypsin (AAT) is a key serine protease inhibitor for regulating proteases such as neutrophil elastase. AAT restrains the pulmonary matrix from enzymatic degradation, and a deficiency in AAT leads to inflammatory tissue damage in the lungs, resulting in chronic obstructive pulmonary disease. Due to the crucial biological function of AAT, the emerging research interest in this protein has shifted to its role in cancer-associated inflammation and the dynamics of the tumor microenvironment. However, the lack of comprehensive reviews in this field hinders our understanding of AAT as an essential immune modulator with great potential in cancer immunotherapy. Therefore, in this review, we have elucidated the pivotal roles of AAT in inflammation and the tumor microenvironment, including the structure and molecular properties of AAT, its molecular functions in the regulation of the inflammatory response and tumor microenvironment, and its clinical implications in cancer including its diagnosis, prognosis, and therapeutic intervention. This review seeks to bridge the gap in the understanding of AAT between inflammatory diseases and cancer, and to foster deeper investigations into its translational potential in cancer immunotherapy in the future.

Verified
Journal Article
Open access
PDF file
ZCZheng Chen
Zheng Chen
SQShuangying Qiao
Shuangying Qiao
LYLiu YANG
Liu YANG
MSMeiheng Sun
Meiheng Sun
BLBoyue LI
Boyue LI
LFLi Fangfei
Li Fangfei
The members of the cytokine interleukin 17 (IL-17) family, along with their receptors (IL-17R), are vital players in a range of inflammatory diseases and cancer. Although generally regarded as proinflammatory, the effects they exhibit on cancer progression are a double-edged sword, with both antitumor and protumor activities being discovered. There is growing evidence that the IL-17 signaling pathways have significant impacts on the tumor microenvironment (TME), immune response, and inflammation in various types of cancer, including pancreatic cancer. However, the detailed mechanistic functions of the IL-17/IL-17R families in pancreatic cancer were rarely systematically elucidated. This review considers the role of the IL-17/IL-17R families in inflammation and tumor immunity and elaborates on the mechanistic functions and correlations of these members with pathogenesis, progression, and chemoresistance in pancreatic cancer. By summarizing the advanced findings on the role of IL-17/IL17R family members and IL-17 signaling pathways at the molecular level, cellular level, and disease level in pancreatic cancer, this review provides an in-depth discussion on the potential of IL-17/IL-17R as prognostic markers and therapeutic targets in pancreatic cancer.

Verified
Journal Article
Open access
PDF file
LYLiu YANG
Liu YANG
SQShuangying Qiao
Shuangying Qiao
GZGe Zhang
Ge Zhang
ALAiping Lu
Aiping Lu
LFLi Fangfei
Li Fangfei
Associations between inflammation and cancer were first discovered approximately 160 years ago by Rudolf Virchow, who observed that tumors were infiltrated with inflammatory cells, and defined inflammation as a pathological condition. Inflammation has now emerged as one of the key mediators in oncogenesis and tumor progression, including pancreatic ductal adenocarcinoma (PDAC). However, the role of inflammatory processes in cancers is complicated and controversial, and the detailed regulatory mechanisms are still unclear. This review elucidates the dynamic interplay between inflammation and immune regulation, microenvironment alteration, metabolic reprogramming, and microbiome risk factors in PDAC, committing to exploring a deeper understanding of the role of crucial inflammatory pathways and molecules for providing insights into therapeutic strategies.

20 October 2013 in Chinese Journal of Natural Medicines
Verified
Journal Article
Closed access
HJHai Jiang
Hai Jiang
YMYong-Hai Meng
Yong-Hai Meng
LYLiu YANG
Liu YANG
QWQiuhong Wang
Qiuhong Wang
BYBing-You Yang
Bing-You Yang
HKHaiXue Kuang
HaiXue Kuang

13 October 2026 in Cells
Verified
Journal Article
Open access
PDF file
XCXinxing CUI
Xinxing CUI
YHYun He
Yun He
LYLiu YANG
Liu YANG
ALAiping Lu
Aiping Lu
LFLi Fangfei
Li Fangfei
Perineural invasion (PNI), the process of tumor cell infiltration of nerves, is a pathological feature of aggressive tumor behavior, correlating with therapeutic resistance and poor clinical outcomes. Cancer-associated fibroblasts (CAFs) have recently emerged as key regulators of PNI. CAFs drive PNI progression through multifaceted mechanisms, including dynamic remodeling of CAF subtypes, neural microenvironment remodeling, and enhancement of tumor–nerve crosstalk via neurotrophic signaling. While various therapeutic approaches targeting CAF surface markers, secreted factors, and intracellular signaling pathways are under investigation, none have yet been translated into clinical practice for PNI management. This review synthesizes current understanding of CAF-mediated PNI, highlights critical knowledge gaps, and proposes future directions. Here, we conceptualize CAF-mediated PNI as a coordinated process linking CAF subtype dynamics, neural niche remodeling, and tumor–nerve crosstalk, rather than as a collection of isolated pro-invasive mechanisms.